Advisortrust Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$260K Sell
719
-11,282
-94% -$3.86M 0.09% 168
2026
Q1
$4.22M Buy
12,001
+862
+8% +$307K 1.76% 14
2025
Q4
$3.65M Buy
+11,139
New +$3.53M 1.6% 16

Other funds holding AMGN

Advisortrust Partners's AMGN Position: Q2 2026 in Review

Advisortrust Partners reduced its Amgen (AMGN) stake by 94% in Q2 2026, selling an estimated $3.86M and leaving 719 shares worth $260K. The position accounts for 0.09% of the portfolio, ranked #168.

Advisortrust Partners first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.22M in Q1 2026. 3,132 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Advisortrust Partners held 719 shares of Amgen worth $260K as of Q2 2026.
  • Advisortrust Partners sold 11,282 Amgen shares in Q2 2026, an estimated $3.86M.
  • Amgen made up 0.09% of Advisortrust Partners's portfolio in Q2 2026, its #168 holding.
  • Advisortrust Partners first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • Advisortrust Partners's Amgen position peaked at $4.22M in Q1 2026.
  • 3,132 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Advisortrust Partners's 13F filing for Q2 2026, filed 10 Aug 2026.